Upper Extremity Injury
23
2
3
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
9%
2 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (23)
Suture Closure Trial
Procedural Sedation and Analgesia for Treatment of Adults With Fractures and Dislocations in the Emergency Department
Survey-Based Study on Recovery Period Differences in Upper Extremity Injuries Among Indoor Climbers by Treatment Method
SoftHand Comparison Study
Effects of Abdominal Bracing Maneuver on the Upper Extremity Performance in Volleyball Athletes
Lower Tourniquet Pressure Study
Rehabilitation Paired with VNS for Motor Function Recovery
Multi-axis Assessment of Injured Workers
Infraclavicular Brachial Plexus Block With Bupivacaine Alone or With Both Dexmedetomidine and Dexamethasone
Pharmacokinetic Analysis of Bupivacaine in the Presence and Absence of Perineural Dexamethasone in Axillary Blockade
Upper Extremity Force-velocity Profile in Swimmers
Interscalene Brachial Plexus Block Washout to Reverse Inadvertent Phrenic Nerve Blockade
Brachial Plexus Block vs. General Anesthesia for Anesthesia Anxiety Before Orthopedic Upper Extremity Surgery
Public Health Risks and Characteristics of Upper Extremity Trauma During COVID-19
Dexametasone Versus Dexametasone Plus Dexmedetomidine in Nerve Blocks
Upper Limb Treatment With "Gloreha Aria" in the Hemiplegic Patients
Ultrasonography in Fracture Management
Throwers Ten Exercises On Upper Extremity Function and Explosive Power in Wheelchair Basketball and Basketball Players
Erector Spinae Plane Versus Interscalene Blocks for Shoulder Surgery
Dexamethasone Versus Dexmedetomidine as Adjuvants for Nerve Blocks